The Changzhou plant will be producing to the capacity of 7,500...

The Changzhou plant will be producing to the capacity of 7,500 MABR units (3 shifts) by Q4 this year on the current 1 line. The Changzhou has the capacity to go up to 3 lines.

I believe the assembly of the Aspiral containers are currently also done in the Changzhou facility, which clogs up valuable space for the other 2 lines. In addition, it also requires more areas to park the empty and loaded containers.

The original plan during Emefcy days was for the Changzhou plant to produce MABR spirals only. I would imagine with the introduction of containerized product, the likes Yiyang assembly plants makes a lot of sense to alleviate the space constraints in Changzhou.

I am seeing the plans will be our IP on MABR production remains in Changzhou, producing up to 3 lines in future, and assembly plants scattered in various cities.

just a back of envelope “not so conservative” calculation now:

from @Relax1 figure of $70,000 per L4 Aspiral unit, which requires 4 spirals of MABR.

Current 7,500 MABR capacity in Changzhou will be able to produce 1,875 L4 units which will be a potential of a revenue of $131m

That will be a big jump for our segment of Smart Package Solution.